Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

European and US Cellulase Patents Granted to Direvo

Published: Wednesday, May 22, 2013
Last Updated: Tuesday, May 21, 2013
Bookmark and Share
Granted patents describe improved cellulase enzymes having CBH II activity.

Direvo Industrial Biotechnology GmbH (Direvo) has announced the granting of U.S. and European Patents covering novel cellulase enzymes.

Cellulase enzymes cleave plant based cellulose into small sugars and are used in numerous applications including production of pulp & paper, biofuels and synthesis of platform chemicals from renewable sources.

The granted patents, “POLYPEPTIDES HAVING CELLOBIOHYDROLASE II ACTIVITY”, describe improved cellulase enzymes having cellobiohydrolase II activity (CBH II) and methods to produce these enzymes.

The CBH II enzymes have higher specific activity and show significantly increased performance compared to available cellulase enzymes.

Direvo´s CEO Jorg Riesmeier stated, “These granted patents will further strengthen our intellectual property portfolio protecting Direvo´s cutting edge technologies, providing additional licensing opportunities and enhancing our competitive market position.”

The invention arose from the unique and well-protected research and discovery platform BluServ™.

The platform allows fast and target-orientated optimization of a vast variety of enzymes and microbial strains.

The effectiveness of this platform has been proven in several projects and resulted in the market launch of superior enzyme products.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!